Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Travel and Lodging | $7,830 | 9 | 47.4% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $4,513 | 7 | 27.3% |
| Food and Beverage | $3,596 | 170 | 21.7% |
| Consulting Fee | $475.00 | 1 | 2.9% |
| Education | $120.85 | 3 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| kaleo, Inc. | $13,159 | 33 | $0 (2024) |
| GENZYME CORPORATION | $940.36 | 53 | $0 (2024) |
| GlaxoSmithKline, LLC. | $648.36 | 40 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $523.21 | 5 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $504.56 | 22 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $199.88 | 11 | $0 (2024) |
| OptiNose US, Inc. | $100.70 | 6 | $0 (2022) |
| SANOFI-AVENTIS U.S. LLC | $98.99 | 1 | $0 (2024) |
| Genentech USA, Inc. | $88.59 | 6 | $0 (2023) |
| Davol Inc. | $86.00 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $14,218 | 57 | kaleo, Inc. ($13,049) |
| 2023 | $496.29 | 27 | GENZYME CORPORATION ($333.95) |
| 2022 | $336.61 | 17 | GENZYME CORPORATION ($125.88) |
| 2021 | $384.12 | 14 | AstraZeneca Pharmaceuticals LP ($183.75) |
| 2020 | $343.26 | 16 | GlaxoSmithKline, LLC. ($197.30) |
| 2019 | $243.77 | 16 | GENZYME CORPORATION ($78.27) |
| 2018 | $287.50 | 21 | GlaxoSmithKline, LLC. ($108.85) |
| 2017 | $225.46 | 22 | GlaxoSmithKline, LLC. ($107.41) |
All Payment Transactions
190 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $35.78 | General |
| Category: Immunology | ||||||
| 11/19/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $14.66 | General |
| Category: IMMUNOLOGY | ||||||
| 11/09/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $15.92 | General |
| Category: Respiratory | ||||||
| 11/01/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $15.57 | General |
| Category: Immunology | ||||||
| 10/30/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $21.00 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/25/2024 | SANOFI-AVENTIS U.S. LLC | DUPIXENT (Biological) | Education | In-kind items and services | $98.99 | General |
| Category: Immunology | ||||||
| 10/25/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $27.51 | General |
| Category: Immunology | ||||||
| 09/13/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.75 | General |
| Category: Immunology | ||||||
| 09/05/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $16.66 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/04/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $20.98 | General |
| Category: Immunology | ||||||
| 08/24/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $13.36 | General |
| Category: Respiratory | ||||||
| 08/02/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $10.38 | General |
| Category: Immunology | ||||||
| 07/31/2024 | kaleo, Inc. | AUVI-Q (Drug) | Food and Beverage | In-kind items and services | $19.62 | General |
| Category: Allergy | ||||||
| 07/26/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.68 | General |
| Category: Immunology | ||||||
| 07/24/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $5.65 | General |
| Category: Immunology | ||||||
| 06/22/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $23.23 | General |
| Category: IMMUNOLOGY | ||||||
| 06/20/2024 | kaleo, Inc. | AUVI-Q (Drug) | Travel and Lodging | Cash or cash equivalent | $1,142.96 | General |
| Category: Allergy | ||||||
| 06/20/2024 | kaleo, Inc. | AUVI-Q (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $475.00 | General |
| Category: Allergy | ||||||
| 06/19/2024 | kaleo, Inc. | AUVI-Q (Drug) | Food and Beverage | In-kind items and services | $98.77 | General |
| Category: Allergy | ||||||
| 06/14/2024 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $22.29 | General |
| Category: Immunology | ||||||
| 06/12/2024 | kaleo, Inc. | AUVI-Q (Drug) | Travel and Lodging | Cash or cash equivalent | $1,773.40 | General |
| Category: Allergy | ||||||
| 06/12/2024 | kaleo, Inc. | AUVI-Q (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $475.00 | General |
| Category: Allergy | ||||||
| 06/12/2024 | kaleo, Inc. | AUVI-Q (Drug) | Travel and Lodging | Cash or cash equivalent | $177.84 | General |
| Category: Allergy | ||||||
| 06/08/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $15.06 | General |
| Category: Respiratory | ||||||
| 06/06/2024 | Novartis Pharmaceuticals Corporation | — | Consulting Fee | Cash or cash equivalent | $475.00 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 238 | 2,746 | $74,360 | $20,235 |
| 2022 | 9 | 261 | 2,903 | $60,094 | $21,584 |
| 2021 | 5 | 178 | 2,049 | $43,464 | $15,853 |
| 2020 | 5 | 158 | 1,593 | $38,530 | $13,060 |
All Medicare Procedures & Services
28 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 54 | 98 | $16,217 | $5,840 | 36.0% |
| 95004 | Test for allergy using allergenic extract | Office | 2023 | 33 | 1,871 | $20,251 | $5,448 | 26.9% |
| 95165 | Professional service for preparation and provision of 1 or more antigens | Office | 2023 | 17 | 340 | $12,340 | $2,938 | 23.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 18 | 18 | $6,072 | $2,304 | 37.9% |
| 95117 | Professional service for multiple injections of allergen | Office | 2023 | 20 | 276 | $10,212 | $2,067 | 20.2% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 35 | 44 | $3,872 | $822.46 | 21.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 11 | 11 | $2,153 | $509.55 | 23.7% |
| 95012 | Test to measure the level of nitric oxide gas | Office | 2023 | 13 | 15 | $761.00 | $178.75 | 23.5% |
| 96160 | Administration and interpretation of patient-focused health risk assessment | Office | 2023 | 37 | 73 | $2,482 | $127.40 | 5.1% |
| 95004 | Test for allergy using allergenic extract | Office | 2022 | 43 | 2,213 | $22,130 | $6,774 | 30.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 63 | 108 | $11,830 | $6,500 | 54.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 24 | 24 | $3,480 | $2,073 | 59.6% |
| 95165 | Professional service for preparation and provision of 1 or more antigens | Office | 2022 | 14 | 230 | $5,750 | $1,961 | 34.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 15 | 15 | $3,300 | $1,758 | 53.3% |
| 95117 | Professional service for multiple injections of allergen | Office | 2022 | 12 | 185 | $6,765 | $1,317 | 19.5% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2022 | 32 | 40 | $3,468 | $746.94 | 21.5% |
| 95012 | Test to measure the level of nitric oxide gas | Office | 2022 | 22 | 24 | $1,200 | $335.16 | 27.9% |
| 96160 | Administration and interpretation of patient-focused health risk assessment | Office | 2022 | 36 | 64 | $2,171 | $117.86 | 5.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 59 | 102 | $11,120 | $5,928 | 53.3% |
| 95004 | Injection of allergenic extracts into skin, accessed through the skin | Office | 2021 | 42 | 1,729 | $17,290 | $5,205 | 30.1% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 43 | 43 | $7,525 | $3,201 | 42.5% |
| 95117 | Injection of incremental dosages of allergen, 2 or more injections | Office | 2021 | 12 | 147 | $5,129 | $980.48 | 19.1% |
| 94010 | Measurement and graphic recording of total and timed exhaled air capacity | Office | 2021 | 22 | 28 | $2,400 | $538.32 | 22.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 56 | 99 | $10,890 | $4,752 | 43.6% |
| 95004 | Injection of allergenic extracts into skin, accessed through the skin | Office | 2020 | 31 | 1,249 | $12,490 | $3,848 | 30.8% |
About Dr. Jeremy Sikora, M.D
Dr. Jeremy Sikora, M.D is a General Practice healthcare provider based in Dayton, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1679667828.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jeremy Sikora, M.D has received a total of $16,535 in payments from pharmaceutical and medical device companies, with $14,218 received in 2024. These payments were reported across 190 transactions from 16 companies. The most common payment nature is "Travel and Lodging" ($7,830).
As a Medicare-enrolled provider, Sikora has provided services to 835 Medicare beneficiaries, totaling 9,291 services with total Medicare billing of $70,732. Data is available for 4 years (2020–2023), covering 28 distinct procedure/service records.
Practice Information
- Specialty General Practice
- Location Dayton, OH
- Active Since 10/03/2006
- Last Updated 08/08/2012
- Taxonomy Code 208D00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1679667828
Products in Payments
- AUVI-Q (Drug) $13,126
- DUPIXENT (Biological) $1,107
- NUCALA (Biological) $570.52
- FASENRA (Biological) $234.61
- DUPIXENT (Drug) $101.60
- Xhance (Drug) $100.70
- Xolair (Biological) $88.59
- AIRSUPRA (Drug) $88.12
- Progel (Device) $86.00
- FASENRA (Drug) $57.86
- TEZSPIRE (Biological) $42.43
- Dymista (Drug) $42.36
- RINVOQ (Biological) $37.39
- TRELEGY ELLIPTA (Drug) $32.28
- Auvi-Q (Drug) $32.16
- DUPIXENT DUPILUMAB INJECTION (Biological) $31.00
- XOLAIR (Biological) $26.61
- AirDuo Digihaler (Drug) $25.06
- XOLAIR (Drug) $21.60
- BEVESPI AEROSPHERE (Drug) $16.96
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
General Practice Doctors in Dayton
Robert Shelhouse, Dds, DDS
General Practice — Payments: $5,314
Mostafa Kabbani, Dds, DDS
General Practice — Payments: $4,990
Ian Rae, D.m.d, D.M.D
General Practice — Payments: $3,759
Dr. John Gazzerro, D.d.s, D.D.S
General Practice — Payments: $2,984
Dr. Sophia Thankaraj, D.d.s, D.D.S
General Practice — Payments: $1,848
Dr. Stephen Frugoli, Dmd, DMD
General Practice — Payments: $1,826